[Role of cyclic adenosine 3,5-monophosphate and prostaglandin E2 in the mechanism of the inhibitory action of nicotinic acid on thrombocyte aggregation].
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000242:Cyclic AMP / Q000502:physiology*; D003864:Depression, Chemical; D015232:Dinoprostone; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D009525:Niacin; D009539:Nicotinic Acids / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D011458:Prostaglandins E / Q000502:physiology*; D013917:Thrombin / Q000494:pharmacology; D013997:Time Factors
D009539:Nicotinic Acids; D011458:Prostaglandins E; D009525:Niacin; D000244:Adenosine Diphosphate; D000242:Cyclic AMP; D013917:Thrombin; D015232:Dinoprostone; D004837:Epinephrine
Issledovanie roli tsiklicheskogo adenozin 3,5-monofosfata i prostaglandina E2 v mekhanizme ingibiruiushchego deĭstviia nikotinovoĭ kisloty na agregatsiiu trombotsitov.